On Friday, Shares of Ventas, Inc. (NYSE:VTR), lost -0.02% to $54.37.
Ventas, said that its Board of Directors declared a regular quarterly dividend of $0.73 per share, payable in cash on December 30, 2015 to stockholders of record on December 21, 2015. The dividend is the fourth quarterly installment of Ventas’s 2015 annual dividend.
Ventas, Inc., an S&P 500 company, is a leading real estate investment trust. Its diverse portfolio of nearly 1,300 assets in the United States, Canada and the United Kingdom comprises of seniors housing communities, medical office buildings, skilled nursing facilities, hospitals and other properties.
Ventas, Inc. is a publicly owned real estate investment trust. The firm engages in investment, administration, financing, and leasing of properties in the healthcare industry. It invests in the real estate markets of the United States and Canada.
Shares of Dyax Corp. (NASDAQ:DYAX), remained flat at $37.36, during its last trading session.
Dyax Corp., declared it has set a date for a special meeting of its stockholders to consider and vote on the formerly declared projected acquisition of Dyax by Shire plc and certain other related matters. The special meeting will be held on January 21, 2016, at 1:00 p.m. Eastern Time, at the offices of Dyax, 55 Network Drive, Burlington, Massachusetts 01803.
Dyax stockholders of record as of the close of business on December 11, 2015 are entitled to notice of, and to vote at, the special meeting. The projected acquisition is subject to approval by Dyax’s stockholders and certain other customary closing conditions.
Dyax Corp., a biopharmaceutical company, identifies, develops, and commercializes treatments for hereditary angioedema (HAE) and other plasma-kallikrein-mediated (PKM) disorders. It offers KALBITOR for the treatment of acute attacks of HAE.
Finally, Mann Kind Corporation (NASDAQ:MNKD), remained flat at $1.53.
Moments ago, Trader’s Choice released new research updates concerning several important developing situations counting the following equities: Mannkind Corp (MNKD), Blue Buffalo Pet Products Inc. (BUFF), Sanchez Energy Corp (SN) and Lumber Liquidators Holdings Inc. (LL). Trader’s Choice has perfected the profitable art of picking stocks, cutting through the noise to deliver the top trade, every year. The full Research Packages are being made available to the public on a complimentary basis.
Highlights from recently’s reports comprise:
On Wednesday, December 9, 2015, Nasdaq Composite ended at 5,022.87, down 1.48%, Dow Jones Industrial Average declined 0.43%, to finish the day at 17,492.30, and the S&P 500 closed at 2,047.62, down 0.77%.
- Mannkind Corp’s stock declined 6.91% to close Wednesday’s session at USD 1.55. The share price vacillated between USD 1.50 and USD 1.61 marking a new 52-week low during the session. The stock recorded a trading volume of 7.64 million shares, which was above its 50-day daily average volume of 6.96 million shares and its 52-week average volume of 6.19 million shares. Over the last three days Mannkind Corp’s shares have declined by 19.69% and in the past one week the stock has moved down 28.57%. Additionally, in the last six months the stock has lost 74.63% and year to date the shares have shed 70.28%. The stock is trading at a price to cash flow ratio of 7.61 with a RSI of 27.13. Mannkind Corp’s stock is trading 29.23% and 44.43% below its 20-day and 50-day simple moving averages, respectively.
- Blue Buffalo Pet Products Inc.’s stock edged higher by 0.06% to close Wednesday’s session at USD 17.71. The company’s shares oscillated between USD 17.46 and USD 17.85. The stock recorded a trading volume of 0.66 million shares, which was below its 50-day daily average volume of 1.44 million shares and its 52-week average volume of 1.56 million shares. Over the last three days Blue Buffalo Pet Products Inc.’s shares have advanced 4.98% and in the past one week the stock has moved up 3.87%. However, over the last three months the stock has lost 20.30%. On a compounded total return basis, the stock has returned 3.87% in the past one week. Further, the stock is trading at a price to earnings ratio of 34.42 and price to sales ratio of 3.47. The stock is presently trading 0.24% above its 20-day simple moving average and 2.53% below its 50-day simple moving average.
- The stock of Sanchez Energy Corp gained 6.78% to close Wednesday’s session at USD 3.94. The shares of the company moved in the range of USD 3.75 and USD 4.22. A trading volume of 2.90 million shares was recorded, which was greater than its 150-day daily average volume of 2.21 million shares and its 52-week average volume of 2.57 million shares. Over the last five days Sanchez Energy Corp’s shares have declined by 16.53% and in the past one month the stock has lost 36.86%. Additionally, over the last three months the stock has declined 33.11% and in the past six months the shares have registered a loss of 62.37%. The stock is trading at a price to sales ratio of 0.39 with a RSI which stood at 32.50. Furthermore, the stock is trading 21.21% below its 20-day simple moving average.
MannKind Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic products for diabetes in the United States. Its lead product is AFREZZA inhalation powder, an insulin to control high blood sugar in adult patients with type 1 and type 2 diabetes. MannKind Corporation was founded in 1991 and is headquartered in Valencia, California.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties, which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified with such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.